PDF herunterladen
CC BY 4.0 · Arq Neuropsiquiatr 2023; 81(06): 585-596
DOI: 10.1055/s-0043-1763485
View and Review

Cognitive impairment in multiple sclerosis: “classic” knowledge and recent acquisitions

Deficiência cognitiva na esclerose múltipla: conhecimentos “clássicos” e aquisições recentes
Chiara Piacentini 
1   Institute of Hospitalization and Care of a Scientific Character “Santa Lucia” Foundation, Behavioral Neuropsychology, Rome, Italy.
,
Ornella Argento 
1   Institute of Hospitalization and Care of a Scientific Character “Santa Lucia” Foundation, Behavioral Neuropsychology, Rome, Italy.
,
Ugo Nocentini 
1   Institute of Hospitalization and Care of a Scientific Character “Santa Lucia” Foundation, Behavioral Neuropsychology, Rome, Italy.
2   University of Rome “Tor Vergata”, Department of Clinical Sciences and Translational Medicine, Rome, Italy.
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Multiple sclerosis (MS) is a central nervous system (CNS) disease characterized by inflammation, axonal demyelination, and neurodegeneration, which can have a strong impact on all aspects of the life of the patient. Multiple sclerosis causes motor, sensory, cerebellar, and autonomic dysfunctions, as well as cognitive and psychoemotional impairment. The most frequently compromised cognitive domains are complex attention/information processing, memory, executive and visuospatial functions. Recently, alterations have also been evidenced in complex cognitive functions, such as social cognition, moral judgment, and decision-making. Cognitive impairment is characterized by high variability and can affect work skills, social interactions, coping strategies and more generally the quality of life of patients and their families. With the use of sensitive and easy-to-administer test batteries, an increasingly accurate and early diagnosis is feasible: this allows to determine the effectiveness of possible preventive measures, to predict the future progression of the disease and to improve the quality of life of patients. There is currently limited evidence regarding the efficacy, on cognitive impairment, of disease-modifying therapies. The most promising approach, which has received strong empirical support, is cognitive rehabilitation.

Resumo

A esclerose múltipla (EM) é uma doença do sistema nervoso central (SNC) caracterizada por inflamação, desmielinização axonal e neurodegeneração, que pode ter um forte impacto em todos os aspectos da vida dos pacientes. A EM causa disfunções motoras, sensoriais, cerebelares, autonômicas, comprometimento cognitivo e déficits psicoemocionais. Os domínios cognitivos mais frequentemente comprometidos são a atenção complexa/processamento da informação, memória, funções executivas e habilidades visuais-espaciais. Recentemente, também foram evidenciadas alterações em funções cognitivas complexas, como cognição social, julgamento moral e tomada de decisão. O comprometimento cognitivo é caracterizado por alta variabilidade e pode afetar as habilidades laborais, as interações sociais, as estratégias de enfrentamento e, de forma mais geral, a qualidade de vida dos pacientes e de seus familiares. Com o uso de baterias de testes sensíveis e fáceis de administrar, é viável um diagnóstico cada vez mais preciso e precoce: isso permite determinar a eficácia de possíveis medidas preventivas, prever a progressão futura da doença e melhorar a qualidade de vida dos pacientes. Atualmente, há evidências limitadas sobre a eficácia, no comprometimento cognitivo, de terapias modificadoras da doença. A abordagem mais promissora, que tem recebido forte apoio empírico, é a reabilitação cognitiva.

Keywords

Multiple Sclerosis - Cognitive Dysfunction - Social Cognition - Decision Making - Neuropsychological Tests - Morale

Palavras-chave

Esclerose Múltipla - Disfunção Cognitiva - Cognição Social - Tomada de Decisões - Testes Neuropsicológicos - Moral

Authors' Contributions

CP, OA: selection and examination of articles – writing – original draft preparation; UN: review & editing. All authors have approved the submitted version of the present manuscript and agree to be personally accountable for the author's own contributions.


Support

The present review was partially funded by the “Baroni” Foundation with a direct scholarship to Chiara Piacentini (Scholarship grant FB.2.1).




Publikationsverlauf

Eingereicht: 11. August 2022

Angenommen: 11. Oktober 2022

Artikel online veröffentlicht:
28. Juni 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 Halabchi F, Alizadeh Z, Sahraian MA, Abolhasani M. Exercise prescription for patients with multiple sclerosis; potential benefits and practical recommendations. BMC Neurol 2017; 17 (01) 185
    CrossrefPubMedSuche in Google Scholar
  • 2 Browne P, Chandraratna D, Angood C. et al. Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity. Neurology 2014; 83 (11) 1022-1024
    CrossrefPubMedSuche in Google Scholar
  • 3 Maggio MG, Russo M, Cuzzola MF. et al. Virtual reality in multiple sclerosis rehabilitation: A review on cognitive and motor outcomes. J Clin Neurosci 2019; 65 (65) 106-111
    CrossrefPubMedSuche in Google Scholar
  • 4 Macías Islas MÁ, Ciampi E. Assessment and Impact of Cognitive Impairment in Multiple Sclerosis: An Overview. Biomedicines 2019; 7 (01) 22
    CrossrefPubMedSuche in Google Scholar
  • 5 DeLuca J, Nocentini U. Neuropsychological, medical and rehabilitative management of persons with multiple sclerosis. NeuroRehabilitation 2011; 29 (03) 197-219
    CrossrefPubMedSuche in Google Scholar
  • 6 Charcot JM. Lectures on the diseases of the nervous system delivered at la Salpetriere,. London:: New Sydenham Society; 1877
    Suche in Google Scholar
  • 7 Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008; 7 (12) 1139-1151
    CrossrefSuche in Google Scholar
  • 8 Kinsinger SW, Lattie E, Mohr DC. Relationship between depression, fatigue, subjective cognitive impairment, and objective neuropsychological functioning in patients with multiple sclerosis. Neuropsychology 2010; 24 (05) 573-580
    CrossrefPubMedSuche in Google Scholar
  • 9 Goverover Y, Chiaravalloti N, DeLuca J. The relationship between self-awareness of neurobehavioral symptoms, cognitive functioning, and emotional symptoms in multiple sclerosis. Mult Scler 2005; 11 (02) 203-212
    CrossrefPubMedSuche in Google Scholar
  • 10 Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991; 41 (05) 685-691
    CrossrefPubMedSuche in Google Scholar
  • 11 Benedict RH, Fischer JS, Archibald CJ. et al. Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol 2002; 16 (03) 381-397
    CrossrefPubMedSuche in Google Scholar
  • 12 Benedict RHB, Amato MP, DeLuca J, Geurts JJG. Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. Lancet Neurol 2020; 19 (10) 860-871
    CrossrefPubMedSuche in Google Scholar
  • 13 Moccia M, Lanzillo R, Palladino R. et al. Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression. Mult Scler 2016; 22 (05) 659-667
    CrossrefPubMedSuche in Google Scholar
  • 14 Dorstyn DS, Roberts RM, Murphy G, Haub R. Employment and multiple sclerosis: A meta-analytic review of psychological correlates. J Health Psychol 2019; 24 (01) 38-51
    CrossrefPubMedSuche in Google Scholar
  • 15 Oset M, Stasiolek M, Matysiak M. Cognitive Dysfunction in the Early Stages of Multiple Sclerosis-How Much and How Important?. Curr Neurol Neurosci Rep 2020; 20 (07) 22
    Suche in Google Scholar
  • 16 Filippi M, Rocca MA, Benedict RH. et al. The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology 2010; 75 (23) 2121-2128
    CrossrefPubMedSuche in Google Scholar
  • 17 Nocentini U, Romano S, Caltagirone C. . I deficit cognitivi nella sclerosi multipla. in Nocentini U, Caltagirone C, Tedeschi G. I disturbi neuropsichiatrici nella sclerosi multipla. Milano: Springer; 2011. 123-144. DOI: https://doi.org/10.1007/978-88-470-1711-5
    Crossref
  • 18 Guimarães J, Sá MJ. Cognitive dysfunction in multiple sclerosis. Front Neurol 2012; 3 (03) 74
    CrossrefPubMedSuche in Google Scholar
  • 19 Oreja-Guevara C, Ayuso Blanco T, Brieva Ruiz L, Hernández Pérez MÁ, Meca-Lallana V, Ramió-Torrentà L. Cognitive Dysfunctions and Assessments in Multiple Sclerosis. Front Neurol 2019; 10 (10) 581
    CrossrefPubMedSuche in Google Scholar
  • 20 Grzegorski T, Losy J. Cognitive impairment in multiple sclerosis - a review of current knowledge and recent research. Rev Neurosci 2017; 28 (08) 845-860
    CrossrefPubMedSuche in Google Scholar
  • 21 DeLuca J, Kalmar JH. . Information Processing Speed in Clinical Populations. New York: Psychology Press; 2007 DOI:
    Crossref
  • 22 Rao SM, St Aubin-Faubert P, Leo GJ. Information processing speed in patients with multiple sclerosis. J Clin Exp Neuropsychol 1989; 11 (04) 471-477
    CrossrefPubMedSuche in Google Scholar
  • 23 Demaree HA, DeLuca J, Gaudino EA, Diamond BJ. Speed of information processing as a key deficit in multiple sclerosis: implications for rehabilitation. J Neurol Neurosurg Psychiatry 1999; 67 (05) 661-663
    CrossrefPubMedSuche in Google Scholar
  • 24 Eizaguirre MB, Vanotti S, Merino Á. et al. The Role of Information Processing Speed in Clinical and Social Support Variables of Patients with Multiple Sclerosis. J Clin Neurol 2018; 14 (04) 472-477
    CrossrefPubMedSuche in Google Scholar
  • 25 Kouvatsou Z, Masoura E, Kimiskidis V. Working Memory Deficits in Multiple Sclerosis: An Overview of the Findings. Front Psychol 2022; 13 (13) 866885
    CrossrefPubMedSuche in Google Scholar
  • 26 Kouvatsou Z, Masoura E, Kiosseoglou G, Kimiskidis VK. Working memory profiles of patients with multiple sclerosis: Where does the impairment lie?. J Clin Exp Neuropsychol 2019; 41 (08) 832-844
    CrossrefPubMedSuche in Google Scholar
  • 27 González Torre JA, Cruz-Gómez ÁJ, Belenguer A, Sanchis-Segura C, Ávila C, Forn C. Hippocampal dysfunction is associated with memory impairment in multiple sclerosis: A volumetric and functional connectivity study. Mult Scler 2017; 23 (14) 1854-1863
    CrossrefPubMedSuche in Google Scholar
  • 28 Tulving E, Schacter DL. Priming and human memory systems. Science 1990; 247 4940 301-306
    CrossrefPubMedSuche in Google Scholar
  • 29 Amato MP, Portaccio E, Goretti B. et al; TuSCIMS Study Group. Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study. Mult Scler 2010; 16 (12) 1474-1482
    CrossrefPubMedSuche in Google Scholar
  • 30 D'Amico E, Leone C, Hayrettin T, Patti F. Can we define a rehabilitation strategy for cognitive impairment in progressive multiple sclerosis? A critical appraisal. Mult Scler 2016; 22 (05) 581-589
    CrossrefPubMedSuche in Google Scholar
  • 31 Rouleau I, Dagenais E, Tremblay A. et al. Prospective memory impairment in multiple sclerosis: a review. Clin Neuropsychol 2018; 32 (05) 922-936
    CrossrefPubMedSuche in Google Scholar
  • 32 Poole JL, Nakamoto T, McNulty T. et al. Dexterity, visual perception, and activities of daily living in persons with multiple sclerosis. Occup Ther Health Care 2010; 24 (02) 159-170
    CrossrefPubMedSuche in Google Scholar
  • 33 Marasescu R, Cerezo Garcia M, Aladro Benito Y. Impairment of visuospatial/visuoconstructional skills in multiple sclerosis patients: the correlation with regional lesion load and subcortical atrophy. Neurologia 2016; 31 (03) 169-175
    CrossrefPubMedSuche in Google Scholar
  • 34 Lopes Costa S, Gonçalves OF, DeLuca J, Chiaravalloti N, Chakravarthi R, Almeida J. The Temporal Dynamics of Visual Processing in Multiple Sclerosis. Appl Neuropsychol Adult 2016; 23 (02) 133-140
    CrossrefPubMedSuche in Google Scholar
  • 35 Cerezo García M, Martín Plasencia P, Aladro Benito Y. Alteration profile of executive functions in multiple sclerosis. Acta Neurol Scand 2015; 131 (05) 313-320
    CrossrefPubMedSuche in Google Scholar
  • 36 Sehanovic A, Smajlovic D, Tupkovic E. et al. Cognitive Disorders in Patients with Multiple Sclerosis. Mater Sociomed 2020; 32 (03) 191-195
    CrossrefPubMedSuche in Google Scholar
  • 37 Drew M, Tippett LJ, Starkey NJ, Isler RB. Executive dysfunction and cognitive impairment in a large community-based sample with Multiple Sclerosis from New Zealand: a descriptive study. Arch Clin Neuropsychol 2008; 23 (01) 1-19
    CrossrefPubMedSuche in Google Scholar
  • 38 Birnboim S, Miller A. Cognitive strategies application of multiple sclerosis patients. Mult Scler 2004; 10 (01) 67-73
    CrossrefPubMedSuche in Google Scholar
  • 39 Dagenais E, Rouleau I, Tremblay A. et al. Prospective memory in multiple sclerosis: The impact of cue distinctiveness and executive functioning. Brain Cogn 2016; 109 (109) 66-74
    CrossrefPubMedSuche in Google Scholar
  • 40 Goitia B, Bruno D, Abrevaya S. et al. The relationship between executive functions and fluid intelligence in multiple sclerosis. PLoS One 2020; 15 (04) e0231868
    CrossrefPubMedSuche in Google Scholar
  • 41 Leavitt VM, Wylie G, Krch D, Chiaravalloti N, DeLuca J, Sumowski JF. Does slowed processing speed account for executive deficits in multiple sclerosis? Evidence from neuropsychological performance and structural neuroimaging. Rehabil Psychol 2014; 59 (04) 422-428
    CrossrefPubMedSuche in Google Scholar
  • 42 Grech LB, Kiropoulos LA, Kirby KM, Butler E, Paine M, Hester R. Executive function is an important consideration for coping strategy use in people with multiple sclerosis. J Clin Exp Neuropsychol 2017; 39 (08) 817-831
    CrossrefPubMedSuche in Google Scholar
  • 43 Ntoskou K, Messinis L, Nasios G. et al. Cognitive and language deficits in multiple sclerosis: comparison of relapsing remitting and secondary progressive subtypes. Open Neurol J 2018; 12 (12) 19-30
    CrossrefSuche in Google Scholar
  • 44 Lebkuecher AL, Chiaravalloti ND, Strober LB. The role of language ability in verbal fluency of individuals with multiple sclerosis. Mult Scler Relat Disord 2021; 50 (50) 102846
    CrossrefPubMedSuche in Google Scholar
  • 45 Brandstadter R, Fabian M, Leavitt VM. et al. Word-finding difficulty is a prevalent disease-related deficit in early multiple sclerosis. Mult Scler 2020; 26 (13) 1752-1764
    CrossrefPubMedSuche in Google Scholar
  • 46 Chanial C, Basaglia-Pappas S, Jacqueline S. et al. Assessment of implicit language and theory of mind in multiple sclerosis. Ann Phys Rehabil Med 2020; 63 (02) 111-115
    CrossrefPubMedSuche in Google Scholar
  • 47 Fyndanis V, Messinis L, Nasios G. et al. Impaired Verb-Related Morphosyntactic Production in Multiple Sclerosis: Evidence From Greek. Front Psychol 2020; 11 (11) 2051
    CrossrefPubMedSuche in Google Scholar
  • 48 Sonkaya AR, Bayazit ZZ. Language Aspects of Patients with Multiple Sclerosis. EJMI 2018; 2 (03) 133-138
    CrossrefSuche in Google Scholar
  • 49 Friesen DC, Luo L, Luk G, Bialystok E. Proficiency and Control in Verbal Fluency Performance across the Lifespan for Monolinguals and Bilinguals. Lang Cogn Neurosci 2015; 30 (03) 238-250
    CrossrefPubMedSuche in Google Scholar
  • 50 Delgado-Álvarez A, Matias-Guiu JA, Delgado-Alonso C. et al. Cognitive Processes Underlying Verbal Fluency in Multiple Sclerosis. Front Neurol 2021; 11 (11) 629183
    CrossrefPubMedSuche in Google Scholar
  • 51 Blecher T, Miron S, Schneider GG, Achiron A, Ben-Shachar M. Association Between White Matter Microstructure and Verbal Fluency in Patients With Multiple Sclerosis. Front Psychol 2019; 10 (10) 1607
    CrossrefPubMedSuche in Google Scholar
  • 52 Naro LD, Spinello RS, Cantone M. et al. Rehabilitative treatment in a case of aphasia as onset of multiple sclerosis. Neurol Sci 2021; 42 (09) 3919-3921
    CrossrefPubMedSuche in Google Scholar
  • 53 Demirkiran M, Ozeren A, Sönmezler A, Bozdemir H. Crossed aphasia in multiple sclerosis. Mult Scler 2006; 12 (01) 116-119
    CrossrefPubMedSuche in Google Scholar
  • 54 Devere TR, Trotter JL, Cross AH. Acute aphasia in multiple sclerosis. Arch Neurol 2000; 57 (08) 1207-1209
    CrossrefPubMedSuche in Google Scholar
  • 55 Brochet B, Ruet A. Cognitive Impairment in Multiple Sclerosis With Regards to Disease Duration and Clinical Phenotypes. Front Neurol 2019; 10 (10) 261
    CrossrefPubMedSuche in Google Scholar
  • 56 Dackovic J, Pekmezovic T, Mesaros S. et al. The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population. Neurol Sci 2016; 37 (09) 1475-1481
    CrossrefPubMedSuche in Google Scholar
  • 57 De Meo E, Portaccio E, Giorgio A. et al. Identifying the Distinct Cognitive Phenotypes in Multiple Sclerosis. JAMA Neurol 2021; 78 (04) 414-425
    CrossrefPubMedSuche in Google Scholar
  • 58 Silveira C, Guedes R, Maia D, Curral R, Coelho R. Neuropsychiatric Symptoms of Multiple Sclerosis: State of the Art. Psychiatry Investig 2019; 16 (12) 877-888
    CrossrefPubMedSuche in Google Scholar
  • 59 Patten SB, Marrie RA, Carta MG. Depression in multiple sclerosis. Int Rev Psychiatry 2017; 29 (05) 463-472
    CrossrefPubMedSuche in Google Scholar
  • 60 Marrie RA, Reingold S, Cohen J. et al. The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult Scler 2015; 21 (03) 305-317
    Suche in Google Scholar
  • 61 Chwastiak LA, Ehde DM. Psychiatric issues in multiple sclerosis. Psychiatr Clin North Am 2007; 30 (04) 803-817
    CrossrefPubMedSuche in Google Scholar
  • 62 Korostil M, Feinstein A. Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler 2007; 13 (01) 67-72
    CrossrefPubMedSuche in Google Scholar
  • 63 Goretti B, Viterbo RG, Portaccio E. et al. Anxiety state affects information processing speed in patients with multiple sclerosis. Neurol Sci 2014; 35 (04) 559-563
    CrossrefPubMedSuche in Google Scholar
  • 64 Morrow SA, Rosehart H, Pantazopoulos K. Anxiety and Depressive Symptoms Are Associated With Worse Performance on Objective Cognitive Tests in MS. J Neuropsychiatry Clin Neurosci 2016; 28 (02) 118-123
    CrossrefPubMedSuche in Google Scholar
  • 65 Ribbons K, Lea R, Schofield PW, Lechner-Scott J. Anxiety Levels Are Independently Associated With Cognitive Performance in an Australian Multiple Sclerosis Patient Cohort. J Neuropsychiatry Clin Neurosci 2017; 29 (02) 128-134
    CrossrefPubMedSuche in Google Scholar
  • 66 Marrie RA, Patel R, Figley CR. et al; Comorbidity and Cognition in Multiple Sclerosis (CCOMS) Study Group. Diabetes and anxiety adversely affect cognition in multiple sclerosis. Mult Scler Relat Disord 2019; 27 (27) 164-170
    CrossrefPubMedSuche in Google Scholar
  • 67 Veauthier C. Sleep disorders in multiple sclerosis. Review. Curr Neurol Neurosci Rep 2015; 15 (05) 21
    CrossrefPubMedSuche in Google Scholar
  • 68 Hughes AJ, Turner AP, Alschuler KN. et al. Association Between Sleep Problems and Perceived Cognitive Dysfunction Over 12 Months in Individuals with Multiple Sclerosis. Behav Sleep Med 2018; 16 (01) 79-91
    CrossrefPubMedSuche in Google Scholar
  • 69 Ayache SS, Chalah MA. Fatigue in multiple sclerosis - Insights into evaluation and management. Neurophysiol Clin 2017; 47 (02) 139-171
    CrossrefPubMedSuche in Google Scholar
  • 70 Nunnari D, De Cola MC, D'Aleo G, Rifici C, Russo M, Sessa E. et al. Impact of depression, fatigue, and global measure of cortical volume on cognitive impairment in multiple sclerosis. Biomed Res Int. 2015; (2015):519785. DOI:
    CrossrefPubMed
  • 71 Morrow SA, Weinstock-Guttman B, Munschauer FE, Hojnacki D, Benedict RH. Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis. Mult Scler 2009; 15 (08) 998-1005
    CrossrefPubMedSuche in Google Scholar
  • 72 Hanken K, Eling P, Hildebrandt H. Is there a cognitive signature for MS-related fatigue?. Mult Scler 2015; 21 (04) 376-381
    CrossrefPubMedSuche in Google Scholar
  • 73 Andreasen AK, Iversen P, Marstrand L, Siersma V, Siebner HR, Sellebjerg F. Structural and cognitive correlates of fatigue in progressive multiple sclerosis. Neurol Res 2019; 41 (02) 168-176
    CrossrefPubMedSuche in Google Scholar
  • 74 Pan H, Wang Y, Wang X, Yan C. Dimethyl fumarate improves cognitive impairment by enhancing hippocampal brain-derived neurotrophic factor levels in hypothyroid rats. BMC Endocr Disord 2022; 22 (01) 188
    CrossrefPubMedSuche in Google Scholar
  • 75 Fahmy EM, Elfayoumy NM, Abdelalim AM, Sharaf SA, Ismail RS, Elshebawy H. Relation of serum levels of homocysteine, vitamin B12 and folate to cognitive functions in multiple sclerosis patients. Int J Neurosci 2018; 128 (09) 835-841
    CrossrefPubMedSuche in Google Scholar
  • 76 Giazkoulidou A, Messinis L, Nasios G. Cognitive functions and social cognition in multiple sclerosis: An overview. Hell J Nucl Med 2019; 22 (22) , Suppl) 102-110
    PubMedSuche in Google Scholar
  • 77 Lin X, Zhang X, Liu Q. et al. Social cognition in multiple sclerosis and its subtypes: A meta-analysis. Mult Scler Relat Disord 2021; 52 (52) 102973
    CrossrefPubMedSuche in Google Scholar
  • 78 Doskas T, Vavougios GD, Karampetsou P. et al. Neurocognitive impairment and social cognition in multiple sclerosis. Int J Neurosci 2021; ;( (25) 1-16
    CrossrefPubMedSuche in Google Scholar
  • 79 van der Hiele K, van Egmond EEA, Jongen PJ. et al. Empathy in multiple sclerosis--Correlates with cognitive, psychological and occupational functioning. Mult Scler Relat Disord 2020; 41 (41) 102036
    CrossrefPubMedSuche in Google Scholar
  • 80 Dulau C, Deloire M, Diaz H. et al. Social cognition according to cognitive impairment in different clinical phenotypes of multiple sclerosis. J Neurol 2017; 264 (04) 740-748
    CrossrefPubMedSuche in Google Scholar
  • 81 Neuhaus M, Bagutti S, Yaldizli Ö. et al. Characterization of social cognition impairment in multiple sclerosis. Eur J Neurol 2018; 25 (01) 90-96
    CrossrefPubMedSuche in Google Scholar
  • 82 Bisecco A, Altieri M, Santangelo G. et al. Resting-State Functional Correlates of Social Cognition in Multiple Sclerosis: An Explorative Study. Front Behav Neurosci 2020; 13 (03) 276
    CrossrefPubMedSuche in Google Scholar
  • 83 Argento O, Spanò B, Serra L. et al. Relapsing-remitting and secondary-progressive multiple sclerosis patients differ in decoding others' emotions by their eyes. Eur J Neurol 2022; 29 (02) 505-514
    CrossrefPubMedSuche in Google Scholar
  • 84 Parada-Fernández P, Oliva-Macías M, Amayra I. et al. Accuracy and reaction time in recognition of facial emotions in people with multiple sclerosis. Rev Neurol 2015; 61 (10) 433-440
    Suche in Google Scholar
  • 85 Luminet O, Bagby RM, Taylor GJ. . Alexithymia: Advances in Theory, Research & Clinical Practice. Cambridge: Cambridge University Press; 2018
  • 86 Raimo S, Trojano L, Pappacena S. et al. Neuropsychological correlates of theory of mind deficits in patients with multiple sclerosis. Neuropsychology 2017; 31 (07) 811-821
    CrossrefPubMedSuche in Google Scholar
  • 87 Chalah MA, Ayache SS. Alexithymia in multiple sclerosis: A systematic review of literature. Neuropsychologia 2017; 104 (104) 31-47
    CrossrefPubMedSuche in Google Scholar
  • 88 Moll J, Zahn R, de Oliveira-Souza R, Krueger F, Grafman J. Opinion: the neural basis of human moral cognition. Nat Rev Neurosci 2005; 6 (10) 799-809
    CrossrefPubMedSuche in Google Scholar
  • 89 Gleichgerrcht E, Tomashitis B, Sinay V. The relationship between alexithymia, empathy and moral judgment in patients with multiple sclerosis. Eur J Neurol 2015; 22 (09) 1295-1303
    CrossrefPubMedSuche in Google Scholar
  • 90 Patil I, Young L, Sinay V, Gleichgerrcht E. Elevated moral condemnation of third-party violations in multiple sclerosis patients. Soc Neurosci 2017; 12 (03) 308-329
    CrossrefPubMedSuche in Google Scholar
  • 91 Lotto L, Manfrinati A, Sarlo M. A new set of moral dilemmas: Norms for moral acceptability, decision times, and emotional salience. J. Behav. Dec. Making 2014; 27 (01) 57-65
    CrossrefSuche in Google Scholar
  • 92 Realmuto S, Dodich A, Meli R. et al. Moral Cognition and Multiple Sclerosis: A Neuropsychological Study. Arch Clin Neuropsychol 2019; 34 (03) 319-326
    CrossrefPubMedSuche in Google Scholar
  • 93 McCabe MP, Stokes M, McDonald E. Changes in quality of life and coping among people with multiple sclerosis over a 2 year period. Psychol Health Med 2009; 14 (01) 86-96
    CrossrefPubMedSuche in Google Scholar
  • 94 Gutbrod K, Krouzel C, Hofer H, Müri R, Perrig W, Ptak R. Decision-making in amnesia: do advantageous decisions require conscious knowledge of previous behavioural choices?. Neuropsychologia 2006; 44 (08) 1315-1324
    CrossrefPubMedSuche in Google Scholar
  • 95 Neuhaus M, Calabrese P, Annoni JM. . Decision-Making in Multiple Sclerosis Patients: A Systematic Review. Mult Scler Int. 2018; ( 2018):7835952. DOI:
    CrossrefPubMed
  • 96 Damasio AR. Descartes Error: Emotion, Reason, and the Human Brain. New York:: Grosset Putmann; 1994
    Suche in Google Scholar
  • 97 Kleeberg J, Bruggimann L, Annoni JM, van Melle G, Bogousslavsky J, Schluep M. Altered decision-making in multiple sclerosis: a sign of impaired emotional reactivity?. Ann Neurol 2004; 56 (06) 787-795
    CrossrefPubMedSuche in Google Scholar
  • 98 Simioni S, Schluep M, Bault N. et al. Multiple sclerosis decreases explicit counterfactual processing and risk taking in decision making. PLoS One 2012; 7 (12) e50718
    CrossrefPubMedSuche in Google Scholar
  • 99 Hoffmann JA, von Helversen B, Rieskamp J. Pillars of judgment: how memory abilities affect performance in rule-based and exemplar-based judgments. J Exp Psychol Gen 2014; 143 (06) 2242-2261
    CrossrefPubMedSuche in Google Scholar
  • 100 Parker AM, de Bruin WB, Fischhoff B, Weller J. Robustness of Decision-Making Competence: Evidence from two measures and an 11-year longitudinal study. J Behav Decis Making 2018; 31 (03) 380-391
    CrossrefPubMedSuche in Google Scholar
  • 101 Hoffmann JA, Bareuther L, Schmidt R, Dettmers C. The relation between memory and decision-making in multiple sclerosis patients. Mult Scler Relat Disord 2020; 37 (37) 101433
    CrossrefPubMedSuche in Google Scholar
  • 102 Zamarian L, Berger T, Pertl MT. et al. Decision making and framing effects in multiple sclerosis. Eur J Neurol 2021; 28 (04) 1292-1298
    CrossrefPubMedSuche in Google Scholar
  • 103 Pettigrew C, Soldan A. Defining Cognitive Reserve and Implications for Cognitive Aging. Curr Neurol Neurosci Rep 2019; 19 (01) 1
    CrossrefPubMedSuche in Google Scholar
  • 104 Sumowski JF, Leavitt VM. Cognitive reserve in multiple sclerosis. Mult Scler 2013; 19 (09) 1122-1127
    CrossrefPubMedSuche in Google Scholar
  • 105 Argento O, Nocentini U. . Neuropsychological assessment in multiple sclerosis. In Ayman El-Baz and Jasjit S Suri. Neurological Disorders and Imaging Physics, Volume 2; Engineering and clinical perspectives of multiple sclerosis. Bristol: IOP ebooks; 2019. 242-264
  • 106 Langdon DW, Amato MP, Boringa J. et al. Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler 2012; 18 (06) 891-898
    CrossrefPubMedSuche in Google Scholar
  • 107 Erlanger DM, Kaushik T, Caruso LS. et al. Reliability of a cognitive endpoint for use in a multiple sclerosis pharmaceutical trial. J Neurol Sci 2014; 340 (1-2): 123-129
    CrossrefPubMedSuche in Google Scholar
  • 108 Pardini M, Uccelli A, Grafman J, Yaldizli Ö, Mancardi G, Roccatagliata L. Isolated cognitive relapses in multiple sclerosis. J Neurol Neurosurg Psychiatry 2014; 85 (09) 1035-1037
    CrossrefPubMedSuche in Google Scholar
  • 109 van Oirschot P, Heerings M, Wendrich K, den Teuling B, Martens MB, Jongen PJ. Symbol Digit Modalities Test Variant in a Smartphone App for Persons With Multiple Sclerosis: Validation Study. JMIR Mhealth Uhealth 2020; 8 (10) e18160
    CrossrefPubMedSuche in Google Scholar
  • 110 Wojcik CM, Beier M, Costello K. et al; National MS Society Cognition Work Team. Computerized neuropsychological assessment devices in multiple sclerosis: A systematic review. Mult Scler 2019; 25 (14) 1848-1869
    CrossrefPubMedSuche in Google Scholar
  • 111 Benedict RH, Munschauer F, Linn R. et al. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Mult Scler 2003; 9 (01) 95-101
    CrossrefPubMedSuche in Google Scholar
  • 112 Chen MH, Goverover Y, Genova HM, DeLuca J. Cognitive Efficacy of Pharmacologic Treatments in Multiple Sclerosis: A Systematic Review. CNS Drugs 2020; 34 (06) 599-628
    CrossrefPubMedSuche in Google Scholar
  • 113 Landmeyer NC, Bürkner PC, Wiendl H. et al. Disease-modifying treatments and cognition in relapsing-remitting multiple sclerosis: A meta-analysis. Neurology 2020; 94 (22) e2373-e2383
    CrossrefPubMedSuche in Google Scholar
  • 114 DeLuca J, Chiaravalloti ND, Sandroff BM. Treatment and management of cognitive dysfunction in patients with multiple sclerosis. Nat Rev Neurol 2020; 16 (06) 319-332
    CrossrefPubMedSuche in Google Scholar
  • 115 Chen MH, Chiaravalloti ND, DeLuca J. Neurological update: cognitive rehabilitation in multiple sclerosis. J Neurol 2021; 268 (12) 4908-4914
    CrossrefPubMedSuche in Google Scholar
  • 116 Tacchino A, Pedullà L, Bonzano L. et al. A New App for At-Home Cognitive Training: Description and Pilot Testing on Patients with Multiple Sclerosis. JMIR Mhealth Uhealth 2015; 3 (03) e85
    CrossrefPubMedSuche in Google Scholar
  • 117 Gómez-Gastiasoro A, Peña J, Ibarretxe-Bilbao N, Lucas-Jiménez O, Díez-Cirarda M, Rilo O. et al. A Neuropsychological Rehabilitation Program for Cognitive Impairment in Psychiatric and Neurological Conditions: A Review That Supports Its Efficacy. Behav Neurol. 2019; (2019):4647134. DOI:
    CrossrefPubMed
  • 118 Gharakhanlou R, Wesselmann L, Rademacher A. et al. Exercise training and cognitive performance in persons with multiple sclerosis: A systematic review and multilevel meta-analysis of clinical trials. Mult Scler 2021; 27 (13) 1977-1993
    CrossrefPubMedSuche in Google Scholar